StockOtters
StockOttersSupply Chain Map
Sichuan Kelun Pharmaceutical Co., Ltd. logo

Sichuan Kelun Pharmaceutical Co., Ltd.

002422.SZ

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
3,054
Cost of Revenue
1,486
Gross Profit
1,568
Gross Margin
51.3%
Operating Income
620
Operating Margin
20.3%
Net Income
411
Net Margin
13.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
735
EBITDA Margin
24.1%

2023

12/31/2023

Revenue
3,004
Cost of Revenue
1,441
Gross Profit
1,563
Gross Margin
52.0%
Operating Income
512
Operating Margin
17.0%
Net Income
344
Net Margin
11.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
643
EBITDA Margin
21.4%

2022

12/31/2022

Revenue
2,665
Cost of Revenue
1,272
Gross Profit
1,394
Gross Margin
52.3%
Operating Income
307
Operating Margin
11.5%
Net Income
239
Net Margin
9.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
478
EBITDA Margin
17.9%

2021

12/31/2021

Revenue
2,419
Cost of Revenue
1,119
Gross Profit
1,300
Gross Margin
53.7%
Operating Income
185
Operating Margin
7.6%
Net Income
154
Net Margin
6.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
377
EBITDA Margin
15.6%

2020

12/31/2020

Revenue
2,305
Cost of Revenue
1,101
Gross Profit
1,204
Gross Margin
52.2%
Operating Income
141
Operating Margin
6.1%
Net Income
116
Net Margin
5.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
333
EBITDA Margin
14.4%